Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy
Materialtyp:
ArtikelUtgivningsinformation: MDPI - Multidisciplinary Digital Publishing Institute 2024Beskrivning: 1 electronic resource (410 p.)Innehållstyp: - text
- computer
- online resource
- 9783725820214
- 9783725820221
- Medicine
- Medical specialties, branches of medicine
- Pharmacology
- AUC
- Bayesian
- Bayesian estimation
- Bayesian models
- CFTR modulators
- GFR
- Gram-positive
- ICU
- LC–MS
- MS
- PD
- PK
- TDM
- Thai patient
- acute lymphoid leukemia
- acute rejection
- antibiotics
- area under the curve
- atrial fibrillation
- bioequivalence
- biological therapy
- biomarkers
- bipolar and related disorders
- busulfan
- cabotegravir
- caftor
- cefiderocol
- cerebrospinal fluid
- children
- clinical practice
- cobicistat
- covariates
- critical ill
- critical illness
- cystic fibrosis
- dalbavancin
- dapagliflozin
- delirium
- depressive disorder
- direct oral anticoagulants
- dose–effect relationship
- dosing nomogram
- dried blood spots
- drug monitoring
- elexacaftor
- endomyocardial biopsies
- external evaluation
- external validation
- fixed-dose combination products
- fungal infection
- ganciclovir
- gentamicin
- glomerular filtration rate
- haloperidol
- heart transplant
- heart transplantation
- imatinib
- intensive care
- isavuconazole
- ivacaftor
- kidney injury
- kinase inhibitors
- laparoscopic sleeve gastrectomy
- limited sampling strategies
- limited-sampling strategy
- linagliptin
- long-acting
- long
Open Access Unrestricted online access star
This compilation is a reprint of the Special Issue "Therapeutic drug monitoring and pharmacokinetics-based individualization of drug therapy" of the peer-reviewed journal Pharmaceutics (ISSN: 1999-4923). The primary aim of this Special Issue was to provide a platform for presenting the findings of research performed using novel computer software-based approaches for the pharmacokinetic interpretation of the results of therapeutic drug monitoring. The compilation involves nineteen research articles and five review papers published between 2022 and 2024. The areas covered include pharmacotherapy following organ transplant, the treatment of the severely or even critically ill using antiinfectives, precision oncology, mental illness, cystic fibrosis, anticoagulant therapy, the treatment of diabetes, and ophthalmology.
Creative Commons Licence cc by-nc-nd cc https://creativecommons.org/licenses/by-nc-nd/4.0/
eng
Freely available e-book